Timothy P Coughlin Insider Trading $NBIX NEUROCRINE BIOSCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Timothy P Coughlin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Timothy P Coughlin. Timothy P Coughlin is Chief Financial Officer in NEUROCRINE BIOSCIENCES INC ($NBIX) and VP and Chief Financial Officer in NEUROCRINE BIOSCIENCES INC ($NBIX).
Timothy P Coughlin in NEUROCRINE BIOSCIENCES INC
Trading Symbol: NBIXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Timothy P Coughlin: VP and Chief Financial Officer
Holdings: 101,374 shares
Current Value: $4,419,906
Latest Transaction: Feb 05 2015
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Timothy P Coughlin in NEUROCRINE BIOSCIENCES INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | A | 32.99 | 80,000 | 2,639,200 | 80,000 | |
Feb 05 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Jan 21 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 30.81 | 1,750 | 53,918 | 101,374 | 103.1 K to 101.4 K (-1.70 %) |
Jan 13 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 28.37 | 1,750 | 49,648 | 99,624 | 101.4 K to 99.6 K (-1.73 %) |
Jan 09 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 100,000 | |
Jan 09 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 27.25 | 10,000 | 272,500 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Jan 09 2015 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 2.59 | 10,000 | 25,900 | 107,874 | 97.9 K to 107.9 K (+10.22 %) |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 110,000 | |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 2.59 | 20,000 | 51,800 | 120,000 | |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 24.02 | 10,000 | 240,200 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 2.59 | 10,000 | 25,900 | 107,874 | 97.9 K to 107.9 K (+10.22 %) |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 23.11 | 10,000 | 231,100 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 23.25 | 10,000 | 232,500 | 107,874 | 117.9 K to 107.9 K (-8.48 %) |
Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 2.59 | 20,000 | 51,800 | 117,874 | 97.9 K to 117.9 K (+20.43 %) |
Dec 12 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 140,000 | |
Dec 12 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 5.12 | 10,000 | 51,200 | 140,000 | |
Dec 12 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 21.95 | 10,000 | 219,500 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Dec 12 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 5.12 | 10,000 | 51,200 | 107,874 | 97.9 K to 107.9 K (+10.22 %) |
Dec 12 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 21.00 | 10,000 | 210,000 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Dec 12 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 2.59 | 10,000 | 25,900 | 107,874 | 97.9 K to 107.9 K (+10.22 %) |
Dec 02 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 5.12 | 10,000 | 51,200 | 10,000 | |
Dec 02 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 20.14 | 10,000 | 201,400 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Nov 03 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 2.59 | 10,000 | 25,900 | 150,000 | |
Nov 03 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 19.00 | 10,000 | 190,000 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Oct 30 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 2.59 | 10,000 | 25,900 | 160,000 | |
Oct 30 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 5.12 | 10,000 | 51,200 | 20,000 | |
Oct 30 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 18.62 | 10,000 | 186,200 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Oct 30 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 18.00 | 10,000 | 180,000 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
Jan 13 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 18.56 | 1,750 | 32,480 | 97,874 | 99.6 K to 97.9 K (-1.76 %) |
Jan 08 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 11.44 | 53,450 | 611,468 | 0 | |
Jan 08 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 11.44 | 16,550 | 189,332 | 53,450 | |
Jan 08 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 16.75 | 70,000 | 1,172,500 | 96,124 | 166.1 K to 96.1 K (-42.14 %) |
Aug 22 2013 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 11.44 | 19,035 | 217,760 | 70,000 | |
Aug 22 2013 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 15.05 | 19,035 | 286,477 | 96,124 | 115.2 K to 96.1 K (-16.53 %) |
Aug 07 2013 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | X | 11.44 | 10,965 | 125,440 | 89,035 | |
Aug 07 2013 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 14.99 | 10,965 | 164,365 | 96,124 | 107.1 K to 96.1 K (-10.24 %) |
Jan 14 2013 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Jan 14 2013 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | A | 8.65 | 86,000 | 743,900 | 86,000 | |
Jan 17 2012 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | A | 8.66 | 120,000 | 1,039,200 | 120,000 | |
Aug 29 2011 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | A | 5.76 | 125,000 | 720,000 | 125,000 | |
Mar 02 2011 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Sell | S | 6.83 | 12,320 | 84,104 | 96,124 | 108.4 K to 96.1 K (-11.36 %) |
May 12 2010 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | A | 2.59 | 170,000 | 440,300 | 170,000 | |
Mar 03 2010 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Sell | S | 2.53 | 12,650 | 31,972 | 75,110 | 87.8 K to 75.1 K (-14.41 %) |
Jan 13 2010 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Sell | S | 2.52 | 8,697 | 21,951 | 54,427 | 63.1 K to 54.4 K (-13.78 %) |
Sep 01 2009 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | D | 47.88 | 2,500 | 119,700 | 0 | |
Sep 01 2009 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | D | 44.77 | 100 | 4,477 | 0 | |
Sep 01 2009 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | D | 45.04 | 4,000 | 180,160 | 0 | |
Sep 01 2009 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Option Exercise | D | 44.70 | 3,750 | 167,625 | 0 | |
Apr 01 2009 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Sell | S | 3.43 | 12,117 | 41,537 | 43,790 | 55.9 K to 43.8 K (-21.67 %) |
Jan 15 2009 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | VP and Chief Financ ... | Sell | S | 3.39 | 8,463 | 28,648 | 22,574 | 31 K to 22.6 K (-27.27 %) |
Page: 1